Life sciences M&A comes with unique challenges that require thoughtful and creative structuring. Bridging valuation gaps between buyers...

Various biotech companies have completed or launched their IPOs so far in 2025. As of early February, five sizeable life sciences...

Underscoring the exceptional value of a firm that’s purpose-built for tech and life sciences, Law360 named Fenwick a 2024 Practice Group...

On December 3, the U.S. Securities and Exchange Commission settled charges against biotherapeutics company Kiromic BioPharma, Inc., its...

After attending the 2024 Digital Health Counsel AI Summit, the transformative impact of AI and data-driven innovation on healthcare is...

With the end of the third quarter quickly approaching, companies may want to consider the following for their upcoming Quarterly Reports...

Life sciences companies are adding risk factor language in response to the U.S. Supreme Court overturning the Chevron Doctrine. As you...

On May 31, 2024, more than four months after the February 2024 Change Healthcare ransomware attack, the U.S. Department of Health and...

On Thursday, June 13, the Supreme Court maintained access to the abortion pill, mifepristone. This medication, in conjunction with...

The deadline is fast approaching for Washington “small businesses” to comply with the state's My Health My Data Act (MHMDA). The MHMDA,...